IP Library › Granted Patent US 6,861,406
Granted Patent B2
US 6,861,406 · App. 10/215,759 · Granted Mar 1, 2005

IGF-binding protein-derived peptide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,861,406
App. No.
10/215,759
Granted
Mar 1, 2005
Kind
B2
Abstract

New compositions based on IGF-binding protein sequences are provided. New tools for high-throughput research are provided. New methods for the treatment of human disease are provided. IGFBP-3-derived peptide or small molecule is administered to subjects having disease, thereby alleviating the symptoms of the disease.

Claims (5)

1. A composition comprising an MBD peptide, said peptide consisting of a peptide selected from the group consisting of GFYKKKQCRPSKGRKRGFCW, OCRPSKGRKRGFC, CRPSKGRKRGFCW, and CRPSKGRKRGFC.

2. The composition of claim 1 , wherein said peptide is GFYKKKQCRPSKGRKRGFCW.

3. The composition of claim 1 , wherein said peptide is QCRPSKGRKRGFC.

4. The composition of claim 1 , wherein said peptide is CRPSKGRKRGFCW.

5. The composition of claim 1 , wherein said peptide is CRPSKGRKRGFC.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2021
From: TRANSPORIN, INC
To: ENMODULIN, INC
Reel/Frame 058769/0528 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2014
From: ONTHERIX, INC.; IPREFERENT, INC.
To: TRANSPORIN
Reel/Frame 034106/0744 →